Protective role of endogenous erythropoietin system in nonhematopoietic cells against pressure overload-induced left ventricular dysfunction in mice

被引:69
|
作者
Asaumi, Yasuhide
Kagaya, Yutaka
Takeda, Morihiko
Yamaguchi, Nobuhiro
Tada, Hiroko
Ito, Kenta
Ohta, Jun
Shiroto, Takashi
Shirato, Kunio
Minegishi, Naoko
Shimokawa, Hiroaki
机构
[1] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Aoba Ku, Sendai, Miyagi 9808574, Japan
[2] Tohoku Univ, Biomed Engn Res Org, Sendai, Miyagi 9808574, Japan
[3] CREST, Japan Sci & Technol Agcy, Tokyo, Japan
关键词
angiogenesis; erythropoietin; heart failure; hypertension; hypertrophy; remodeling;
D O I
10.1161/CIRCULATIONAHA.106.659037
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background-Erythropoietin ( Epo) receptors ( EpoRs) are expressed in the heart. We have recently demonstrated that the endogenous Epo-EpoR system plays an important protective role in myocardial ischemia in mice and humans. In the present study, we tested our hypothesis that the endogenous Epo-EpoR system in nonhematopoietic cells also plays a protective role against pressure overload-induced cardiac dysfunction in vivo. Methods and Results-Transgene-rescued EpoR-null mutant mice ( EpoR(rescued)(-/-)) that express EpoR exclusively in the hematopoietic cells were subjected to transverse aortic constriction ( TAC). At 1 week after TAC, left ventricular weight and lung weight were significantly increased in EpoR(rescued)(-/-) mice compared with wild-type mice, although the fibrotic area was comparably increased after TAC in the 2 genotypes. In the EpoR(rescued)(-/-) mice with TAC, left ventricular end-diastolic diameter was significantly increased, left ventricular fractional shortening was significantly decreased, and survival rate was significantly decreased compared with wild-type mice with TAC. Phosphorylation of STAT3 at 5 hours and 1 week after TAC and that of p38 at 5 hours after TAC were significantly increased in wild-type mice but not in EpoR(rescued)(-/-) mice. Vascular endothelial growth factor protein expression and capillary density in left ventricular myocardium were significantly decreased in EpoR(rescued)(-/-) mice with TAC compared with wild-type mice with TAC. Conclusions-These results suggest that the endogenous Epo-EpoR system in the nonhematopoietic cells plays an important protective role against pressure overload-induced cardiac dysfunction in vivo.
引用
收藏
页码:2022 / 2032
页数:11
相关论文
共 50 条
  • [21] The Long Pentraxin PTX3 Exacerbates Pressure Overload-induced Left Ventricular Dysfunction
    Suzuki, Satoshi
    Shishido, Tetsuro
    Kitahara, Tatsuro
    Sasaki, Toshiki
    Kato, Shigehiko
    Ishino, Mitsunori
    Watanabe, Tetsu
    Takeishi, Yasuchika
    Kubota, Isao
    CIRCULATION, 2009, 120 (18) : S802 - S802
  • [22] Deletion of Interleukin-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction
    Zhao, Lin
    Cheng, Guangming
    Jin, Runming
    Afzal, Muhammad R.
    Samanta, Anweshan
    Xuan, Yu-Ting
    Girgis, Magdy
    Elias, Harold K.
    Zhu, Yanqing
    Davani, Arash
    Yang, Yanjuan
    Chen, Xing
    Ye, Sheng
    Wang, Ou-Li
    Chen, Lei
    Hauptman, Jeryl
    Vincent, Robert J.
    Dawn, Buddhadeb
    CIRCULATION RESEARCH, 2016, 118 (12) : 1918 - +
  • [23] Long Pentraxin PTX3 Exacerbates Pressure Overload-Induced Left Ventricular Dysfunction
    Suzuki, Satoshi
    Shishido, Tetsuro
    Funayama, Akira
    Netsu, Shunsuke
    Ishino, Mitsunori
    Kitahara, Tatsuro
    Sasaki, Toshiki
    Katoh, Shigehiko
    Otaki, Yoichiro
    Watanabe, Tetsu
    Shibata, Yoko
    Mantovani, Alberto
    Takeishi, Yasuchika
    Kubota, Isao
    PLOS ONE, 2013, 8 (01):
  • [24] Xanthine Oxidase Inhibition With Febuxostat Attenuates Systolic Overload-Induced Left Ventricular Hypertrophy and Dysfunction in Mice
    Xu, Xin
    Hu, Xinli
    Lu, Zhongbing
    Zhang, Ping
    Zhao, Lin
    Wessale, Jerry L.
    Bache, Robert J.
    Chen, Yingjie
    JOURNAL OF CARDIAC FAILURE, 2008, 14 (09) : 746 - 753
  • [25] The antioxidant edaravone attenuates pressure overload-induced left ventricular hypertrophy
    Tsujimoto, I
    Hikoso, S
    Yamaguchi, O
    Kashiwase, K
    Nakai, A
    Takeda, T
    Watanabe, T
    Taniike, M
    Matsumura, Y
    Nishida, K
    Hori, M
    Kogo, M
    Otsu, K
    HYPERTENSION, 2005, 45 (05) : 921 - 926
  • [26] Effects of enalapril in cats with pressure overload-induced left ventricular hypertrophy
    Ishikawa, Yumi
    Uechi, Masami
    Hori, Yasutomo
    Ebisawa, Takashi
    Yamano, Shigeki
    Enomoto, Youko
    Ugai, Jun
    JOURNAL OF FELINE MEDICINE AND SURGERY, 2007, 9 (01) : 29 - 35
  • [27] HMGB1 Aggravates Pressure Overload-Induced Left Ventricular Dysfunction by Promoting Myocardial Fibrosis
    Zhang, Lei
    Yu, Ying
    Yu, Peng
    Wu, Jian
    Sun, Aijun
    Zou, Yunzeng
    Su, Yangang
    Jiang, Hong
    Ge, Junbo
    INTERNATIONAL JOURNAL OF HYPERTENSION, 2020, 2020
  • [28] Zerumbone prevents pressure overload-induced left ventricular systolic dysfunction by inhibiting cardiac hypertrophy and fibrosis
    Sari, Nurmila
    Katanasaka, Yasufumi
    Sugiyama, Yuga
    Sunagawa, Yoichi
    Miyazaki, Yusuke
    Funamoto, Masafumi
    Shimizu, Satoshi
    Shimizu, Kana
    Murakami, Akira
    Mori, Kiyoshi
    Wada, Hiromichi
    Hasegawa, Koji
    Morimoto, Tatsuya
    PHYTOMEDICINE, 2021, 92
  • [29] Genetic Deletion of IL-6 Attenuates Pressure Overload-Induced Left Ventricular Hypertrophy and Dysfunction
    Sanganalmath, Santosh K.
    James, Christine R.
    Taher, Hisham
    Hunt, Greg
    Vincent, Robert J.
    Wu, Rui
    Li, Qianhong
    Flaherty, Michael P.
    Bolli, Roberto
    Dawn, Buddhadeb
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A149 - A149
  • [30] Effect of Pentraxin 3 on Pressure Overload-Induced Left Ventricular Hypertrophy
    Suzuki, Satoshi
    Shishido, Tetsuro
    Funayama, Akira
    Netsu, Shunsuke
    Takeishi, Yasuchika
    CIRCULATION RESEARCH, 2012, 111 (04)